Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer

BACKGROUND: There is no consensus regarding the secondary cytoreduction surgery (CRS) in recurrent ovarian cancer patients. The present study aims to determine the value of secondary CRS and the eligible subgroup for this procedure. METHODS: 96 platinum-sensitive recurrent ovarian cancer patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xia, Chen, Xiaoxiang, Dai, Zhiqin, Deng, Fei, Qu, Junwei, Ni, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847054/
https://www.ncbi.nlm.nih.gov/pubmed/24059600
http://dx.doi.org/10.1186/1756-9966-32-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847054/
https://www.ncbi.nlm.nih.gov/pubmed/24059600
http://dx.doi.org/10.1186/1756-9966-32-61

Ejemplares similares